Loading patent…
AssigneesDana-Farber Cancer Institute, Inc., University of Vermont and State Agricultural College
InventorsRichard D. Kolodner, Robert A. G. Reenan, Richard Fishel
Estimating the term…
We have now discovered that eukaryotes, including mammals, have a DNA mismatch repair pathway analogous to the pathway that exists in bacteria. Defects or alterations in this mismatch repair pathway in a mammal, such as a human, will result in the accumulation of unstable repeated DNA sequences. Such a phenotype has a high correlation to disease state in a number of cancers, such as hereditary colon cancers. Accordingly, discovering a defect or alteration in the pathway can be diagnostic of a predisposition to cancer, and prognostic for a particular cancer. We have also discovered and sequenced one of the genes in this pathway in a number of mammals, including humans. This gene, referred to herein as MSH2, has many applications. It can be used in assays, to express gene product, for drug screens, and therapeutically. We also disclose herein a method for screening for other genes in this mismatch repair pathway.
An isolated nucleotide segment having the sequence as set forth in SEQ ID NO:
An isolated nucleic acid segment having a nucleotide sequence selected from the group consisting of SEQ ID NOs:
An isolated nucleotide segment, wherein said nucleotide segment is SEQ ID NO:
An isolated nucleotide segment, wherein said nucleotide sequence is selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.